NCT07395258
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07395258
Title A Study to Test Different Doses of BI 3923948 Alone and in Combination With an Anti-PD-1 Antibody in People With Different Types of Advanced Cancer (Solid Tumors)
Recruitment Not yet recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Boehringer Ingelheim
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | SWE | FRA | ESP | DEU

Facility Status City State Zip Country Details
Indiana University Indianapolis Indiana 46202 United States Details
University of Minnesota Minneapolis Minnesota 55414 United States Details
The University of Texas MD Anderson Cancer Center Houston Texas 77030 United States Details
Fred Hutchinson Cancer Research Center Seattle Washington 98109 United States Details
CTR Leon Berard Lyon 69373 France Details
INS Gustave Roussy Villejuif 94800 France Details
Universitätsklinikum Heidelberg Heidelberg 69120 Germany Details
Hospital Clínic de Barcelona Barcelona 08036 Spain Details
Hospital Clinico De Valencia (INCLIVA) Valencia 46010 Spain Details
Karolinska Universitetssjukhuset Stockholm Stockholm 17177 Sweden Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field